Squarepoint Ops LLC - AVADEL PHARMACEUTICALS PLC ownership

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 83 filers reported holding AVADEL PHARMACEUTICALS PLC in Q4 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of AVADEL PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2023$150,195
-21.0%
14,582
-48.2%
0.00%
-100.0%
Q2 2021$190,000
+75.9%
28,162
+135.3%
0.00%0.0%
Q1 2021$108,000
-71.5%
11,968
-78.9%
0.00%
-66.7%
Q4 2020$379,000
+23.1%
56,666
-7.4%
0.00%
-25.0%
Q3 2020$308,00061,1650.00%
Other shareholders
AVADEL PHARMACEUTICALS PLC shareholders Q4 2020
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 985,210$10,345,0006.10%
Broadfin Capital, LLC 3,568,122$37,465,0005.54%
JW Asset Management, LLC 444,439$4,667,0003.42%
ARMISTICE CAPITAL, LLC 1,688,000$17,724,0002.09%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,655,494$38,383,0001.73%
FALCON POINT CAPITAL, LLC 661,490$6,284,0000.91%
KNOTT DAVID M 158,555$1,665,0000.71%
Perceptive Advisors 3,098,010$32,530,0000.62%
Sio Capital Management, LLC 91,413$960,0000.50%
HEARTLAND ADVISORS INC 700,000$7,350,0000.48%
View complete list of AVADEL PHARMACEUTICALS PLC shareholders